The University of Chicago Header Logo

Connection

Harriet De Wit to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications Harriet De Wit has written about Dose-Response Relationship, Drug.
Harriet De Wit
Connection Strength
3.863
Dose-Response Relationship, Drug
  1. Neural complexity is increased after low doses of LSD, but not moderate to high doses of oral THC or methamphetamine. Neuropsychopharmacology. 2024 Jun; 49(7):1120-1128.
    View in: PubMed
    Score: 0.683
  2. Microdosing Psychedelics: Current Evidence From Controlled Studies. Biol Psychiatry Cogn Neurosci Neuroimaging. 2024 May; 9(5):500-511.
    View in: PubMed
    Score: 0.171
  3. Subjective responses to amphetamine in young adults with previous mood elevation experiences. Psychopharmacology (Berl). 2019 Nov; 236(11):3363-3370.
    View in: PubMed
    Score: 0.124
  4. Acute Subjective and Behavioral Effects of Microdoses of Lysergic Acid Diethylamide in Healthy Human Volunteers. Biol Psychiatry. 2019 11 15; 86(10):792-800.
    View in: PubMed
    Score: 0.124
  5. Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress. Drug Alcohol Depend. 2017 08 01; 177:136-144.
    View in: PubMed
    Score: 0.108
  6. Oxytocin receptor gene variation predicts subjective responses to MDMA. Soc Neurosci. 2016 12; 11(6):592-9.
    View in: PubMed
    Score: 0.098
  7. Naltrexone alters the processing of social and emotional stimuli in healthy adults. Soc Neurosci. 2016 12; 11(6):579-91.
    View in: PubMed
    Score: 0.098
  8. 'Ecstasy' as a social drug: MDMA preferentially affects responses to emotional stimuli with social content. Soc Cogn Affect Neurosci. 2014 Aug; 9(8):1076-81.
    View in: PubMed
    Score: 0.086
  9. Effects of MDMA and Intranasal oxytocin on social and emotional processing. Neuropsychopharmacology. 2014 Jun; 39(7):1654-63.
    View in: PubMed
    Score: 0.085
  10. MDMA decreases the effects of simulated social rejection. Pharmacol Biochem Behav. 2014 Feb; 117:1-6.
    View in: PubMed
    Score: 0.084
  11. Inattention, impulsive action, and subjective response to D-amphetamine. Drug Alcohol Depend. 2013 Nov 01; 133(1):127-33.
    View in: PubMed
    Score: 0.082
  12. Psychopharmacology of theobromine in healthy volunteers. Psychopharmacology (Berl). 2013 Jul; 228(1):109-18.
    View in: PubMed
    Score: 0.080
  13. Personality and the acute subjective effects of d-amphetamine in humans. J Psychopharmacol. 2013 Mar; 27(3):256-64.
    View in: PubMed
    Score: 0.080
  14. Pre-encoding administration of amphetamine or THC preferentially modulates emotional memory in humans. Psychopharmacology (Berl). 2013 Apr; 226(3):515-29.
    View in: PubMed
    Score: 0.079
  15. Do initial responses to drugs predict future use or abuse? Neurosci Biobehav Rev. 2012 Jul; 36(6):1565-76.
    View in: PubMed
    Score: 0.076
  16. Amping up effort: effects of d-amphetamine on human effort-based decision-making. J Neurosci. 2011 Nov 16; 31(46):16597-602.
    View in: PubMed
    Score: 0.073
  17. Effects of amphetamine on reactivity to emotional stimuli. Psychopharmacology (Berl). 2012 Mar; 220(1):143-53.
    View in: PubMed
    Score: 0.073
  18. Effect of d-amphetamine on post-error slowing in healthy volunteers. Psychopharmacology (Berl). 2012 Mar; 220(1):109-15.
    View in: PubMed
    Score: 0.072
  19. Combined effects of acute, very-low-dose ethanol and delta(9)-tetrahydrocannabinol in healthy human volunteers. Pharmacol Biochem Behav. 2011 Feb; 97(4):627-31.
    View in: PubMed
    Score: 0.069
  20. Effects of acute progesterone administration upon responses to acute psychosocial stress in men. Exp Clin Psychopharmacol. 2010 Feb; 18(1):78-86.
    View in: PubMed
    Score: 0.065
  21. Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking: an exploratory study with d-amphetamine in healthy participants. Exp Clin Psychopharmacol. 2009 Dec; 17(6):374-83.
    View in: PubMed
    Score: 0.064
  22. Effects of MDMA on sociability and neural response to social threat and social reward. Psychopharmacology (Berl). 2009 Nov; 207(1):73-83.
    View in: PubMed
    Score: 0.063
  23. The prescription opioid, oxycodone, does not alter behavioral measures of impulsivity in healthy volunteers. Pharmacol Biochem Behav. 2009 Nov; 94(1):108-13.
    View in: PubMed
    Score: 0.063
  24. Bupropion improves attention but does not affect impulsive behavior in healthy young adults. Exp Clin Psychopharmacol. 2008 Apr; 16(2):113-23.
    View in: PubMed
    Score: 0.057
  25. Personality and gender differences in effects of d-amphetamine on risk taking. Exp Clin Psychopharmacol. 2007 Dec; 15(6):599-609.
    View in: PubMed
    Score: 0.056
  26. Serotonin transporter genotype and acute subjective response to amphetamine. Am J Addict. 2006 Sep-Oct; 15(5):327-35.
    View in: PubMed
    Score: 0.051
  27. Personality and the subjective effects of acute amphetamine in healthy volunteers. Neuropsychopharmacology. 2006 May; 31(5):1064-74.
    View in: PubMed
    Score: 0.050
  28. Association between the casein kinase 1 epsilon gene region and subjective response to D-amphetamine. Neuropsychopharmacology. 2006 May; 31(5):1056-63.
    View in: PubMed
    Score: 0.050
  29. Subjective, behavioral, and physiological effects of acute caffeine in light, nondependent caffeine users. Psychopharmacology (Berl). 2006 May; 185(4):514-23.
    View in: PubMed
    Score: 0.049
  30. Acute-alcohol effects on the Experiential Discounting Task (EDT) and a question-based measure of delay discounting. Pharmacol Biochem Behav. 2006 Feb; 83(2):194-202.
    View in: PubMed
    Score: 0.049
  31. Therapeutic doses of diazepam do not alter impulsive behavior in humans. Pharmacol Biochem Behav. 2004 Sep; 79(1):17-24.
    View in: PubMed
    Score: 0.044
  32. Effects of THC on behavioral measures of impulsivity in humans. Neuropsychopharmacology. 2003 Jul; 28(7):1356-65.
    View in: PubMed
    Score: 0.041
  33. Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans. Psychopharmacology (Berl). 2002 Jun; 161(4):331-9.
    View in: PubMed
    Score: 0.038
  34. Lack of effects of acute estradiol on mood in postmenopausal women. Pharmacol Biochem Behav. 2002 Jan-Feb; 71(1-2):71-7.
    View in: PubMed
    Score: 0.037
  35. Lack of effect of intravenous hydrocortisone on mood in humans: a preliminary study. Behav Pharmacol. 2001 Sep; 12(5):373-6.
    View in: PubMed
    Score: 0.036
  36. Effects of a single dose of baclofen on self-reported subjective effects and tobacco smoking. Nicotine Tob Res. 2001 May; 3(2):123-9.
    View in: PubMed
    Score: 0.035
  37. Effects of d-amphetamine and ethanol on a measure of behavioral inhibition in humans. Behav Neurosci. 2000 Aug; 114(4):830-7.
    View in: PubMed
    Score: 0.034
  38. Effects of ethanol at four phases of the menstrual cycle. Psychopharmacology (Berl). 2000 Jul; 150(4):374-82.
    View in: PubMed
    Score: 0.033
  39. Responses to oral delta9-tetrahydrocannabinol in frequent and infrequent marijuana users. Pharmacol Biochem Behav. 1999 May; 63(1):137-42.
    View in: PubMed
    Score: 0.031
  40. Individual differences in subjective responses to ethanol and triazolam. Behav Pharmacol. 1999 May; 10(3):283-95.
    View in: PubMed
    Score: 0.031
  41. Ethanol impairs saccadic and smooth pursuit eye movements without producing self-reports of sedation. Alcohol Clin Exp Res. 1999 Apr; 23(4):664-72.
    View in: PubMed
    Score: 0.031
  42. Delay or probability discounting in a model of impulsive behavior: effect of alcohol. J Exp Anal Behav. 1999 Mar; 71(2):121-43.
    View in: PubMed
    Score: 0.030
  43. Individual differences in the biphasic effects of ethanol. Alcohol Clin Exp Res. 1998 Dec; 22(9):1903-11.
    View in: PubMed
    Score: 0.030
  44. Effects of expectancies on subjective responses to oral delta9-tetrahydrocannabinol. Pharmacol Biochem Behav. 1998 Feb; 59(2):287-93.
    View in: PubMed
    Score: 0.028
  45. Behavioral responses to ethanol in light and moderate social drinkers following naltrexone pretreatment. Drug Alcohol Depend. 1997 Aug 25; 47(2):109-16.
    View in: PubMed
    Score: 0.027
  46. Acute effects of triazolam in women: relationships with progesterone, estradiol and allopregnanolone. Psychopharmacology (Berl). 1997 Mar; 130(1):69-78.
    View in: PubMed
    Score: 0.026
  47. The effects of ethanol on the relative preference for cigarettes. Behav Pharmacol. 1997 Feb; 8(1):75-81.
    View in: PubMed
    Score: 0.026
  48. Individual differences in timing of peak positive subjective responses to d-amphetamine: Relationship to pharmacokinetics and physiology. J Psychopharmacol. 2016 Apr; 30(4):330-43.
    View in: PubMed
    Score: 0.025
  49. Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers. Biol Psychiatry. 1996 Jan 01; 39(1):26-32.
    View in: PubMed
    Score: 0.024
  50. Acute subjective responses to paroxetine in normal volunteers. Drug Alcohol Depend. 1995 Oct; 39(3):223-30.
    View in: PubMed
    Score: 0.024
  51. Effects of acute doses of prosocial drugs methamphetamine and alcohol on plasma oxytocin levels. J Clin Psychopharmacol. 2015 Jun; 35(3):308-12.
    View in: PubMed
    Score: 0.023
  52. Opioid modulation of resting-state anterior cingulate cortex functional connectivity. J Psychopharmacol. 2014 Dec; 28(12):1115-24.
    View in: PubMed
    Score: 0.022
  53. Plasma oxytocin concentrations following MDMA or intranasal oxytocin in humans. Psychoneuroendocrinology. 2014 Aug; 46:23-31.
    View in: PubMed
    Score: 0.022
  54. Relationship between subjective effects and drug preferences: ethanol and diazepam. Drug Alcohol Depend. 1994 Feb; 34(3):243-51.
    View in: PubMed
    Score: 0.021
  55. Subjective, behavioral, and physiologic responses to intravenous dezocine in healthy volunteers. Anesth Analg. 1992 Apr; 74(4):523-30.
    View in: PubMed
    Score: 0.019
  56. Effects of fasting on responses to intravenous fentanyl in healthy volunteers. J Subst Abuse. 1992; 4(2):197-207.
    View in: PubMed
    Score: 0.018
  57. Subjective and behavioral responses to intravenous fentanyl in healthy volunteers. Psychopharmacology (Berl). 1992; 107(2-3):319-26.
    View in: PubMed
    Score: 0.018
  58. Preference procedures for testing the abuse liability of drugs in humans. Br J Addict. 1991 Dec; 86(12):1579-86.
    View in: PubMed
    Score: 0.018
  59. Effects of food deprivation on subjective effects and self-administration of marijuana in humans. Psychol Rep. 1991 Jun; 68(3 Pt 2):1263-74.
    View in: PubMed
    Score: 0.018
  60. Behavioral and subjective effects of ethanol: relationship to cerebral metabolism using PET. Alcohol Clin Exp Res. 1990 Jun; 14(3):482-9.
    View in: PubMed
    Score: 0.017
  61. Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology. 2008 Nov; 33(12):2791-800.
    View in: PubMed
    Score: 0.014
  62. Attenuated cortisol response to alcohol in heavy social drinkers. Int J Psychophysiol. 2006 Mar; 59(3):203-9.
    View in: PubMed
    Score: 0.012
  63. Interindividual variation in anxiety response to amphetamine: possible role for adenosine A2A receptor gene variants. Am J Med Genet B Neuropsychiatr Genet. 2005 Nov 05; 139B(1):42-4.
    View in: PubMed
    Score: 0.012
  64. Subjective effects of slow-release bupropion versus caffeine as determined in a quasi-naturalistic setting. Pharmacology. 2004 Apr; 70(4):206-15.
    View in: PubMed
    Score: 0.011
  65. Effects of morphine and naltrexone on impulsive decision making in rats. Psychopharmacology (Berl). 2004 Apr; 173(1-2):167-74.
    View in: PubMed
    Score: 0.011
  66. Effects of d-amphetamine and alcohol on a measure of behavioral inhibition in rats. Behav Neurosci. 2000 Aug; 114(4):838-848.
    View in: PubMed
    Score: 0.008
  67. Reinforcing effects of extended inhalation of nitrous oxide in humans. Drug Alcohol Depend. 1993 Feb; 31(3):265-80.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.